Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 45,641 | 57,172 | 56,888 | 41,935 | 53,567 |
| Operating Income | -45,641 | -57,172 | -56,888 | -41,935 | -53,567 |
| Other Income | -23,364 | -5,358 | 45,705 | 5,218 | 8,779 |
| Pre-tax Income | -69,005 | -62,530 | -11,183 | -36,717 | -44,788 |
| Income Tax | N/A | N/A | N/A | N/A | -15 |
| Net Income Continuous | -69,005 | -62,530 | -11,183 | -36,717 | -44,773 |
| Net Income | $-69,005 | $-62,530 | $-11,183 | $-36,717 | $-44,773 |
| EPS Basic Total Ops | -0.74 | -1.18 | -0.15 | -0.49 | -0.60 |
| EPS Basic Continuous Ops | -0.88 | -0.89 | -0.19 | -0.61 | -0.74 |
| EPS Diluted Total Ops | -0.74 | -1.18 | -0.15 | -0.49 | -0.60 |
| EPS Diluted Continuous Ops | -0.88 | -0.89 | -0.19 | -0.61 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.70 | -0.15 | -0.49 | -0.74 |
| EBITDA(a) | $-45,641 | $-57,172 | $-56,888 | $-41,935 | $-53,567 |